Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC

Leukemia, Published online: 12 August 2023; doi:10.1038/s41375-023-02004-wRisk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC

https://www.nature.com/articles/s41375-023-02004-w

Source: Leukemia - August 12, 2023 Category: Hematology Authors: Sandra Huber Constance Baer Stephan Hutter Frank Dicker Irene Fuhrmann Manja Meggendorfer Christian Pohlkamp Wolfgang Kern Torsten Haferlach Claudia Haferlach Gregor Hoermann Source Type: research

More News: Hematology | Leukemia